SCARPA, ALDO
 Distribuzione geografica
Continente #
NA - Nord America 2.692
AS - Asia 379
EU - Europa 271
SA - Sud America 4
AF - Africa 1
OC - Oceania 1
Totale 3.348
Nazione #
US - Stati Uniti d'America 2.689
CN - Cina 184
SG - Singapore 175
IT - Italia 116
DE - Germania 34
FR - Francia 27
FI - Finlandia 26
SE - Svezia 21
GB - Regno Unito 16
NL - Olanda 11
IN - India 8
RU - Federazione Russa 7
HK - Hong Kong 5
BR - Brasile 4
CA - Canada 3
ES - Italia 3
CH - Svizzera 2
IE - Irlanda 2
PK - Pakistan 2
UA - Ucraina 2
AT - Austria 1
AU - Australia 1
AZ - Azerbaigian 1
BD - Bangladesh 1
DK - Danimarca 1
JP - Giappone 1
KR - Corea 1
PL - Polonia 1
RO - Romania 1
SC - Seychelles 1
SY - Repubblica araba siriana 1
Totale 3.348
Città #
Fairfield 519
Chandler 250
Ashburn 213
Woodbridge 205
Seattle 200
Houston 192
Cambridge 180
Singapore 150
Santa Clara 129
Wilmington 125
Ann Arbor 75
Boardman 73
Beijing 64
San Diego 54
Medford 41
Princeton 40
Des Moines 29
Roxbury 27
Frankfurt am Main 24
Padova 24
Helsinki 22
Nanjing 16
Milan 12
Aprilia 9
New York 9
Shenyang 7
Guangzhou 6
Hebei 5
Pune 5
Verona 5
Alassio 4
Amsterdam 4
Borås 4
Dallas 4
Hong Kong 4
Munich 4
Shanghai 4
Acton 3
Avezzano 3
Ercolano 3
Florence 3
Jinan 3
Kilburn 3
Lamezia Terme 3
Ogden 3
Washington 3
Zhengzhou 3
Aversa 2
Bari 2
Bauru 2
Belluno 2
Buffalo 2
Changsha 2
Chengdu 2
Cusano Milanino 2
Dublin 2
Fontaniva 2
Karachi 2
Lanzhou 2
Lappeenranta 2
London 2
Madrid 2
Naples 2
Ningbo 2
Norwalk 2
Parma 2
Rockville 2
Squillace 2
Sulmona 2
Taiyuan 2
Turin 2
Vicenza 2
Aarau 1
Americana 1
Augusta 1
Baku 1
Chicago 1
Chiswick 1
Edinburgh 1
Ferrara 1
Foggia 1
Fort Worth 1
Fuzhou 1
Genazzano 1
Haikou 1
Hangzhou 1
Hounslow 1
Hyderabad 1
Jiaxing 1
Kharkiv 1
Leeds 1
Los Angeles 1
Mahé 1
Melbourne 1
Montreal 1
Naaldwijk 1
Nanchang 1
Narsingdi 1
Nashville 1
New Bedfont 1
Totale 2.846
Nome #
Immunosuppression by monocytic myeloid-derived suppressor cells in patients with pancreatic ductal carcinoma is orchestrated by STAT3 148
The Disabled homolog 2 controls pro-metastatic activity of tumor-associated macrophages 126
MIR21 drives resistance to Heat Shock Protein 90 inhibition in cholangiocarcinoma 116
Most high-grade neuroendocrine tumours of the lung are likely to secondarily develop from pre-existing carcinoids: innovative findings skipping the current pathogenesis paradigm 116
Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours 107
Genetic alterations analysis in prognostic stratified groups identified TP53 and ARID1A as poor clinical performance markers in intrahepatic cholangiocarcinoma 103
Gene expression profiling of lung atypical carcinoids and large cell neuroendocrine carcinomas identifies three transcriptomic subtypes with specific genomic alterations 102
Pancreatic undifferentiated carcinoma with osteoclast-like giant cells is genetically similar to, but clinically distinct from, conventional ductal adenocarcinoma 101
Circulating miR-182 is a biomarker of colorectal adenocarcinoma progression 101
Comprehensive molecular portrait using next generation sequencing of resected intestinal-type gastric cancer patients dichotomized according to prognosis 100
Induction of immunosuppressive functions and NF-κB by FLIP in monocytes 95
PD-1, PD-L1, and CD163 in pancreatic undifferentiated carcinoma with osteoclast-like giant cells: expression patterns and clinical implications 94
Extranodal extension of nodal metastases is a poor prognostic moderator in non-small cell lung cancer: a meta-analysis 91
RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: Correlation of expression, chromosomal status and epigenetic changes 91
ERG alterations and mTOR pathway activation in primary prostate carcinomas developing castration-resistance 91
Targeted next-generation sequencing identifies genomic abnormalities potentially driving the prognosis of early-stage invasive lobular breast carcinoma patients stratified according to a validated clinico-pathological model 87
New genomic landscapes and therapeutic targets for biliary tract cancers 84
Mutational and copy number asset of primary sporadic neuroendocrine tumors of the small intestine 83
Extranodal extension of lymph node metastasis influences recurrence in prostate cancer: A systematic review and meta-Analysis 81
Molecular alterations associated with metastases of solid pseudopapillary neoplasms of the pancreas 73
Pembrolizumab Activity in Recurrent High-Grade Gliomas with Partial or Complete Loss of Mismatch Repair Protein Expression: A Monocentric, Observational and Prospective Pilot Study 70
Prognostic impact of proliferation for resected early stage ‘pure’ invasive lobular breast cancer: Cut-off analysis of Ki67 according to histology and clinical validation 66
Cell of origin markers identify different prognostic subgroups of lung adenocarcinoma 66
Inflammatory and tumor-like lesions of the pancreas 66
PBRM1 loss is a late event during the development of cholangiocarcinoma 65
Genomic Characterization of Biliary Tract Cancers Identifies Driver Genes and Predisposing Mutations 62
Malignant epithelial/exocrine tumors of the pancreas 58
Different Prognostic Roles Of Tumor Suppressor Gene BAP1 In Cancer: A Systematic Review With Meta-Analysis 57
Comparative Lesions Analysis Through a Targeted Sequencing Approach 57
Modulation of biliary cancer chemo-resistance through microRNA-mediated rewiring of the expansion of CD133+ cells 57
Exosomal miRNA signatures of pancreatic lesions 57
PD-L1 and Notch as novel biomarkers in pancreatic sarcomatoid carcinoma: a pilot study 53
Current prognostic and predictive biomarkers for gastrointestinal tumors in clinical practice 51
Solid Pseudopapillary Neoplasm of the Pancreas and Abdominal Desmoid Tumor in a Patient Carrying Two Different BRCA2 Germline Mutations: New Horizons from Tumor Molecular Profiling 49
Homologous Recombination Deficiency in Pancreatic Cancer: A Systematic Review and Prevalence Meta-Analysis 44
Molecular biology of neuroendocrine tumors 38
Molecular Analysis of an Intestinal Neuroendocrine/Non-neuroendocrine Neoplasm (MiNEN) Reveals MLH1 Methylation-driven Microsatellite Instability and a Monoclonal Origin: Diagnostic and Clinical Implications 36
Artificial intelligence-based tools applied to pathological diagnosis of microbiological diseases 34
"Pure" hepatoid tumors of the pancreas harboring CTNNB1 somatic mutations: a new entity among solid pseudopapillary neoplasms 30
Genomic characterization of undifferentiated sarcomatoid carcinoma of the pancreas 26
CD117 Is a Specific Marker of Intraductal Papillary Mucinous Neoplasms (IPMN) of the Pancreas, Oncocytic Subtype 25
Acinar Cystic Transformation of the Pancreas: Histomorphology and Molecular Analysis to Unravel its Heterogeneous Nature 25
Colorectal cancer with microsatellite instability: Right-sided location and signet ring cell histology are associated with nodal metastases, and extranodal extension influences disease-free survival 24
Genomic characterization of hepatoid tumors: context matters 23
The Evolution of Surgical Strategies for Pancreatic Neuroendocrine Tumors (Pan-NENs): Time-trend and Outcome Analysis From 587 Consecutive Resections at a High-volume Institution 22
Histo-molecular characterization of pancreatic cancer with microsatellite instability: intra-tumor heterogeneity, B2M inactivation, and the importance of metastatic sites 22
Modulation of pancreatic cancer cell sensitivity to FOLFIRINOX through microRNA-mediated regulation of DNA damage 21
Screening/surveillance programs for pancreatic cancer in familial high-risk individuals: A systematic review and proportion meta-analysis of screening results 20
Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Pancreatic Cancer: Systematic Review and Still-Open Questions 18
Are Cystic Pancreatic Neuroendocrine Tumors an Indolent Entity? Results from a Single-Center Surgical Series 18
Integrative characterization of intraductal tubulopapillary neoplasm (ITPN) of the pancreas and associated invasive adenocarcinoma 18
Real-world data on NGS diagnostics: A survey from the Italian Society of Pathology (SIAPeC) NGS Network 17
Does Size Matter in Pancreatic Cancer?: Reappraisal of Tumour Dimension as a Predictor of Outcome Beyond the TNM 15
Radiofrequency ablation for locally advanced pancreatic cancer: SMAD4 analysis segregates a responsive subgroup of patients 14
Comparison of imaging-based and pathological dimensions in pancreatic neuroendocrine tumors 13
Patterns of recurrence after resection for pancreatic neuroendocrine tumors: who, when, and where? 13
European evidence-based guidelines on pancreatic cystic neoplasms 12
The tumour immune microenvironment and microbiome of pancreatic intraductal papillary mucinous neoplasms 10
Reassessment of the Optimal Number of Examined Lymph Nodes in Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma 9
Systematic review, meta-analysis, and a high-volume center experience supporting the new role of mural nodules proposed by the updated 2017 international guidelines on IPMN of the pancreas 9
Pancreatectomy with venous resection for pT3 head adenocarcinoma: Perioperative outcomes, recurrence pattern and prognostic implications of histologically confirmed vascular infiltration 8
Verona Evidence-Based Meeting (EBM) 2020 on Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: Meeting Report 6
Revision of Pancreatic Neck Margins Based on Intraoperative Frozen Section Analysis Is Associated With Improved Survival in Patients Undergoing Pancreatectomy for Ductal Adenocarcinoma 5
Does Site Matter? Impact of Tumor Location on Pathologic Characteristics, Recurrence, and Survival of Resected Pancreatic Ductal Adenocarcinoma 5
Multi-institutional Development and External Validation of a Nomogram to Predict Recurrence After Curative Resection of Pancreatic Neuroendocrine Tumors 4
Hemodynamics and remodeling of the portal confluence in patients with malignancies of the pancreatic head: a pilot study towards planned and circumferential vein resections 4
Genetic Analysis of Small Well-differentiated Pancreatic Neuroendocrine Tumors Identifies Subgroups With Differing Risks of Liver Metastases 4
Solid pseudopapillary tumors of the pancreas: Specific pathological features predict the likelihood of postoperative recurrence 3
Totale 3.419
Categoria #
all - tutte 19.062
article - articoli 18.785
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 277
Totale 38.124


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020369 0 0 0 0 0 0 61 78 93 73 38 26
2020/2021528 23 30 30 45 12 9 45 57 55 124 81 17
2021/2022635 19 86 94 36 30 8 66 63 32 11 52 138
2022/2023466 87 58 11 64 58 47 2 34 55 25 19 6
2023/2024329 6 39 43 43 18 38 35 4 16 11 40 36
2024/2025533 15 119 89 46 202 52 10 0 0 0 0 0
Totale 3.419